Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Piru Perampalam

Chief Scientific Officer & Co-founder

Copoly.ai

Toronto, Canada

2 profile visits

CSO and co-founder of Copoly.ai, a Canadian AI biotech building OncoSage (blood-based early cancer detection), OfficeSage (sovereign GenAI for government), and BioSage (biopharma research platform). PhD biochemistry; ex-Roche & Genentech.

My organisation

Copoly.ai

Copoly.ai

SME

Toronto, Canada

Copoly.ai is an Ontario-based AI and life sciences company dedicated to improving how cancer is detected and diagnosed. Its flagship platform, OncoSage, is a blood-based early cancer detection solution that combines advanced multi-omics and artificial intelligence to identify cancer at very early stages, with a current focus on lung cancer. By aiming to make testing more accessible, less invasive, and more cost-effective, Copoly.ai is building tools that can support earlier intervention, improve clinical decision-making, and expand access to precision diagnostics in real-world healthcare settings.
Read more

About me

Piru Perampalam is the co-founder and Chief Scientific Officer of Copoly.ai, a Canadian-based AI biotech company developing OncoSage, a blood-based early cancer detection platform built on platelet signatures and proprietary AI models. OncoSage is designed to make early, pan-cancer screening accessible through a simple blood draw, with ongoing clinical validation in partnership with London Health Sciences Centre and active international collaborations.

Alongside OncoSage, Piru leads Copoly's two complementary lines of work: OfficeSage, a sovereign, Microsoft 365–integrated generative AI platform tailored for Canadian federal departments and regulated enterprises, and BioSage, an AI-powered bioinrofmatics research platform biopharma partners.

Social media